Hyperhomocysteinemia-related serum metabolome alterations not normalized by short-term folic acid treatment
- 9 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Metabolomics
- Vol. 17 (5), 1-11
- https://doi.org/10.1007/s11306-021-01798-z
Abstract
Introduction Hyperhomocysteinemia (HHCys) is an independent risk factor for various diseases such as cardiovascular diseases, Alzheimer’s, and cancers. Folate deficiency is one of the significant reasons for HHCys. However, it is not known whether folate deficiency with HHCys is associated with any serum metabolites. Objectives Our objective was to identify the metabolic alterations in people having folate deficiency with HHCys and check whether a short-term folic acid therapy could reverse those metabolic changes. Methods The study enrolled 34 participants aged between 18 and 40 years having folate deficiency (< 4.6 ng/mL) with HHCys (> 15 μmol/L) and 21 normal healthy individuals. A short-term intervention of oral folic acid (5 mg/day) was done in the HHCys group for 30 days. Untargeted metabolomics analysis of serum was performed in all study subjects before and after the folic acid treatment. Different univariate methods and the multivariable-adjusted linear regression models were employed to determine an association between homocysteine level and metabolite profile. Results Metabolomics analysis data showed that many metabolites involved in the biochemical pathways of lipid metabolisms such as polyunsaturated fatty acids, glycerolipids, and phospholipids were downregulated in the HHCys group. Short-term oral folic acid therapy significantly reduced their serum homocysteine level. However, the metabolic pathway alterations observed in folate-deficient HHCys-condition were unaltered even after the folic acid treatment. Conclusions Our study revealed that people who have a folic acid deficiency with HHCys have an altered metabolite profile related to lipid metabolism, which cannot be reversed by short-term folic acid therapy.Funding Information
- Kerala State Council for Science, Technology and Environment (005/SRSHS/2014/CSTE)
This publication has 41 references indexed in Scilit:
- Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trialsClinical Nutrition, 2013
- Knowledge and periconceptional use of folic acid for the prevention of neural tube defects in ethnic communities in the United Kingdom: Systematic review and meta‐analysisBirth Defects Research Part A: Clinical and Molecular Teratology, 2013
- Folate Intake,MthfrGenotype, and Sex Modulate Choline Metabolism in MiceJournal of Nutrition, 2011
- Steatosis in Mice Is Associated with Gender, Folate Intake, and Expression of Genes of One-Carbon MetabolismJournal of Nutrition, 2010
- Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke PreventionStroke, 2010
- Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in WomenDiabetes, 2009
- The Homocysteine ParadoxArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Disruption of lipid metabolism in the liver of the pregnant rat fed folate-deficient and methyl donor-deficient dietsBritish Journal of Nutrition, 2008
- Folic acid and cognition in older personsExpert Opinion on Drug Safety, 2006
- Effect of experimental folate deficiency on lipid metabolism in liver and brainBritish Journal of Nutrition, 1982